These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 601547)

  • 1. Absorption of rifampicin in gastrectomized patients. Effect of meals.
    Hagelund CH; Wåhlén P; Eidsaunet W
    Scand J Respir Dis; 1977 Oct; 58(5):241-6. PubMed ID: 601547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1976; 57(1):5-11. PubMed ID: 1273544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
    Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
    Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine--rifampicin interaction.
    Purohit SD; Johri SC; Gupta PR; Mehta YR; Bhatnagar M
    J Assoc Physicians India; 1992 May; 40(5):308-10. PubMed ID: 1483989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probenecid on serum rifampicin levels.
    Pankaj R; Lal S; Rao RS
    Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on pharmacokinetics of rifampicin in the body of patients with pulmonary tuberculosis.
    Pawlowska I; Pniewski T
    Arzneimittelforschung; 1979; 29(12):1906-11. PubMed ID: 546432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis.
    Langdon G; Wilkins JJ; Smith PJ; McIlleron H
    Int J Tuberc Lung Dis; 2004 Jul; 8(7):862-7. PubMed ID: 15260278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on the pharmacokinetics of rifampicin between the old and middle-aged tuberculosis patients].
    Weng FH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):292-4, 319. PubMed ID: 2085859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
    Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rifampicin metabolism in bodies of patients with pulmonary tuberculosis. I].
    Pawlowska I; Pniewski T
    Gruzlica; 1973 Mar; 41(3):225-33. PubMed ID: 4696135
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
    Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Kriukov VL
    Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.